Search Results 1811-1820 of 2729 for 씨밀레토토

  1. Open-Label Extension Study Of Setmelanotide - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. A Study Of Navicixizumab Monotherapy Or In Combination In Patients With Select Advanced Solid Tumors - Mayo Clinic

    Cohort B: Gastric and gastroesophageal junction (GEJ) cancer;; Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory ...

  3. Clinical Trial Of SP-2577 (Seclidemstat) In Patients With Relapsed Or Refractory Ewing Or Ewing-related Sarcomas - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of SP-2577 (seclidemstat) as a single agent and in combination with topotecan and ...

  4. A First-in-Human, Phase 1 Dose-Escalation And Cohort Expansion Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of BJ-005 In Patients With Advanced Solid Tumor Or Lymphoma - Mayo Clinic

    BJ-005 is a recombinant bifunctional molecule, composed of a humanized anti-PD-L1 IgG1 monoclonal antibody (mAb) fused with a portion of the extracellular ...

  5. Venetoclax-Dexamethasone In Relapsed And/or Refractory T(11;14) Amyloidosis - Mayo Clinic

    The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethasone in participants with t(11;14) ...

  6. Treatment Of Peripheral Arterial Hemorrhage With Lava LES (The LAVA Study) - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of the Lava LES for the embolic treatment of arterial hemorrhage in the peripheral ...

  7. VE303 For Prevention Of Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14- ...

  8. TransCon (TC) TLR7/​8 Agonist, TC IL-2 Β/​γ, Pembrolizumab Prior To Surgery For Advanced Head And Neck Squamous Cell Carcinoma (BelieveIT-201) - Mayo Clinic

    Clinical Trials · TransCon (TC) TLR7/​8 Agonist, TC IL-2 Β/​γ, Pembrolizumab Prior To Surgery For Advanced Head And Neck Squamous Cell Carcinoma (BelieveIT-201).

  9. Tai Chi To Optimize Transplant Outcomes For Multiple Myeloma - Mayo Clinic

    About this study. The current proposal aims to test the feasibility of immune function analysis for Tai Chi Easy (TCE) intervention in multiple myeloma (MM) ...

  10. Nivolumab With Or Without Ipilimumab In Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...